10-K/A: Biotricity Inc. Refiles Annual Report to Include Auditor Consent

Biotricity Inc. has refiled its annual report on Form 10-K/A to include the consent of its independent registered public accounting firm, SRCO Professional Corporation.

Summary

• Biotricity Inc. has filed an amendment to its annual report on Form 10-K for the fiscal year ended March 31, 2024.
• The primary reason for this amendment is to include the re-filed consent of the company's independent registered public accounting firm, SRCO Professional Corporation.
• The company has also included updated certifications in this amendment.
• No other information from the original Form 10-K has been amended or changed.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as the company is taking corrective action to ensure compliance. The refiling itself is not a positive event, but the company's response is.

Positives

• The company has taken steps to ensure compliance by refiling the annual report with the required auditor consent.
• The inclusion of updated certifications from the CEO and CFO demonstrates a commitment to accurate financial reporting.

Risks

• The need to refile the annual report may indicate a potential weakness in the company's initial filing process.
• The company is a smaller reporting company, which may have less stringent reporting requirements but also potentially higher risks.

Management Comments

• Waqaas Al-Siddiq, CEO, certified that the report does not contain any untrue statements and fairly presents the company's financial condition.
• John Ayanoglou, CFO, also certified the accuracy and fairness of the financial information in the report.

Industry Context

This filing is a standard regulatory requirement for publicly traded companies, ensuring transparency and compliance with SEC regulations. The refiling highlights the importance of accurate and complete financial reporting.

Comparison to Industry Standards

• The refiling of the annual report to include the auditor's consent is a standard procedure to ensure compliance with SEC regulations, similar to what other publicly traded companies must do.
• The company's market capitalization of approximately $16.3 million is relatively small compared to larger companies in the medical technology sector, such as Medtronic or Boston Scientific, which have market caps in the tens or hundreds of billions.
• The company's share count of 21.4 million is also relatively low compared to larger companies, which often have hundreds of millions or billions of shares outstanding.

Stakeholder Impact

• Shareholders can have increased confidence in the accuracy of the company's financial reporting due to the inclusion of the auditor's consent.
• The refiling ensures compliance with regulatory requirements, which is important for maintaining investor trust.

Key Dates

Keywords

Biotricity, Annual Report, Form 10-K, SEC Filing, Auditor Consent, Financial Reporting, SRCO Professional Corporation, Amendment, NASDAQ, BTCY